Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.1B | 10.2B | 8.4B | 9.3B |
Cost of revenue | 7.4B | 8.4B | 6.8B | 7.6B |
Gross profit | 1.7B | 1.8B | 1.5B | 1.6B |
Operating expense | ||||
Research & development | 483.8M | 777.6M | 467.7M | 470.3M |
Selling general and admin | 532.0M | 541.6M | 1.1B | 54.9M |
Other operating expenses | 63.8M | 99.5M | 61.3M | 71.1M |
Operating income | 735.5M | 1.2B | 731.9M | 747.4M |
Non operating interest income | ||||
Income | 91.0M | 118.6M | 90.1M | 110.2M |
Expense | 418.9M | 452.3M | 304.5M | 292.2M |
Other income expense | — | — | — | — |
Pretax income | 99.3M | 841.7M | 169.6M | 240.6M |
Tax provision | -2.8M | 95.6M | 74.1M | -35.7M |
Net income | 102.0M | 746.1M | 95.5M | 276.3M |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 1.7B | — | — | — |
Diluted average shares | 1.7B | — | — | — |
EBITDA | 859.3M | 1.5B | 664.6M | 885.8M |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.4M | 48.3M | 45.7M | -74.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |